Enhertu 100 MG vials
Ended Awarded Last action
- Contract number
- SPE2DR26F1AW0
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $19,262
Award facts
- Contract value 100% obligated
- $19,262.40 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on January 28, 2026, for the supply of 100 mg vials of Enhertu, a specialty pharmaceutical product commonly used in oncology treatment. This firm fixed-price delivery order, valued at $19,262.40, represents a child contract action under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical. The contract is not set-aside and was competitively awarded, with performance scheduled at the company's corporate office location in Conshohocken, Pennsylvania, and an ultimate completion date of February 19, 2026. AmerisourceBergen Drug Corp is a subsidiary of Cencora, Inc. (doing business as AmerisourceBergen), a major pharmaceutical distributor serving federal military and veteran healthcare systems.
This delivery order is executed under AmerisourceBergen's comprehensive single-award IDC with DLA Troop Support Medical valued at up to $999,999,999.00 through December 2031, which provides a global pharmaceutical supply mechanism for military treatment facilities and federal healthcare programs. The parent company, Cencora, Inc., holds significant contract vehicles across multiple federal agencies and has demonstrated consistent capability in delivering specialized pharmaceutical products across diverse therapeutic domains. The DLA's Medical Supply Chain continues to utilize established prime vendor relationships to ensure reliable delivery of critical medications and medical supplies to support military healthcare operations worldwide.
Quick answers
Who was awarded contract SPE2DR26F1AW0?
SPE2DR26F1AW0 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on January 28, 2026.
How much is contract SPE2DR26F1AW0 worth?
The government has obligated $19,262 on SPE2DR26F1AW0.
Is contract SPE2DR26F1AW0 an order under another contract?
Yes. SPE2DR26F1AW0 is a delivery order under SPE2DR25D1205, an indefinite delivery contract.
Was contract SPE2DR26F1AW0 competed?
The extent of competition for SPE2DR26F1AW0 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award